Group 1 pharmacist interview INTRODUCTION AND SCREENING Good (…). My name is (…). I’m calling from the on behalf of the team evaluating the and Diabetes MedsCheck’ pilot program. May I please speak to ‘MedsCheck <PRIMARYNAME>? IF PRIMARY CONTACT UNAVAILABLE: Then may I please speak to <ALTERNATIVENAME>? IF PRIMARY AND ALTERNATIVE CONTACT BOTH NO LONGER WORKING THERE OR BOTH UNAVAILABLE FOR DURATION: Could I please speak to a pharmacist working today, who may be familiar with the MedsCheck and Diabetes MedsCheck program? IF NECESSARY: It’s the medicines management service, and diabetes medicines management service, currently being piloted by the Department of Health and Ageing under the Fifth Community Pharmacy Agreement. We believe your pharmacy registered to provide these services starting in August 2011. *(NAMED OR NOMINATED PERSON) We’re conducting a short survey on behalf of the Deloitte Access Economics team evaluating this pilot program for the Department of Health and Ageing. They would like to understand the reasons why some pharmacies, who registered to take part in the pilot, have not provided these services or not submitted forms to the Department for payment. Your participation in the interview will help to refine the MedsCheck and Diabetes MedsCheck program so it’s delivered more efficiently and effectively. IF REQUESTED: For technical advice, you can contact the 5CPA helpline on 1300 555 262. 1. Continue 2. to know how they were chosen (GOTO ASELECT) 3. Stop interview, make appointment (RECORD NAME AND ARRANGE CALL BACK) 4. Business refusal (ATTEMPT CONVERSION / RECORD REASON) (GOTO RR1) 5. Respondent refusal (ATTEMPT CONVERSION / RECORD REASON) (GOTO RR1) 6. Queried about how telephone number was obtained (DISPLAY ATELQ) 7. Denies pharmacy registered in MedsCheck pilot (CONFIRM / GOTO TERM1)
Group 1 pharmacist interview INTRODUCTION AND SCREENING Good (…). My name is (…). I’m calling from the on behalf of the team evaluating the ‘MedsCheck and Diabetes MedsCheck’ pilot program. May I please speak to <PRIMARYNAME>? IF PRIMARY CONTACT UNAVAILABLE: Then may I please speak to <ALTERNATIVENAME>? IF PRIMARY AND ALTERNATIVE CONTACT BOTH NO LONGER WORKING THERE OR BOTH UNAVAILABLE FOR DURATION: Could I please speak to a pharmacist working today, who may be familiar with the MedsCheck and Diabetes MedsCheck program? IF NECESSARY: It’s the medicines management service, and diabetes medicines management service, currently being piloted by the Department of Health and Ageing under the Fifth Community Pharmacy Agreement. We believe your pharmacy registered to provide these services starting in August 2011. *(NAMED OR NOMINATED PERSON) We’re conducting a short survey on behalf of the Deloitte Access Economics team evaluating this pilot program for the Department of Health and Ageing. They would like to understand the reasons why some pharmacies, who registered to take part in the pilot, have not provided these services or not submitted forms to the Department for payment. Your participation in the interview will help to refine the MedsCheck and Diabetes MedsCheck program so it’s delivered more efficiently and effectively. IF REQUESTED: For technical advice, you can contact the 5CPA helpline on 1300 555 262. 1. Continue 2. to know how they were chosen (GOTO ASELECT) 3. Stop interview, make appointment (RECORD NAME AND ARRANGE CALL BACK) 4. Business refusal (ATTEMPT CONVERSION / RECORD REASON) (GOTO RR1) 5. Respondent refusal (ATTEMPT CONVERSION / RECORD REASON) (GOTO RR1) 6. Queried about how telephone number was obtained (DISPLAY ATELQ) 7. Denies pharmacy registered in MedsCheck pilot (CONFIRM / GOTO TERM1)